PRCT today
$23.51+$0.17 (+0.73%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bearish
Daily trend turns down below $16.74
Key levels
Resistance$25.95
Resistance$24.07
Support$21.56
Support$19.41
Latest news & SEC filings
SEC FilingPROCEPT BioRobotics Corp filed an insider trading report (Form 4)
AnalystTruist Securities keeps PROCEPT BioRobotics at Hold, lifts price target to $24
AnalystTruist Securities keeps Hold rating on PROCEPT BioRobotics, lifts price target to $24
AnalystUBS keeps PROCEPT BioRobotics at Neutral, lifts target to $21
All PRCT news →About PROCEPT BioRobotics
PROCEPT BioRobotics makes robotic systems used in urologic surgery. Its AquaBeam and HYDROS platforms, paired with a disposable handpiece, perform Aquablation therapy to treat benign prostatic hyperplasia by removing prostate tissue with a waterjet. Customers are mainly hospitals and urologists in the United States, along with distributors, surgery centers, and leasing companies, plus some international markets.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
PROCEPT BioRobotics Corp (PRCT)
What Is the Price Target for PRCT?
SEPT Low Target
$21.00
SEPT Mid Target
$25.00
SEPT High Target
$35.00
Analyst Consensus
$25.00
Is PRCT a Buy or Sell Right Now?
Thesis
- •Revenue growing 37.2% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PRCT.
Start Free Trial →Is PRCT Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$22.24
41
Moat Score
NARROW
3/9
Piotroski Score
3.8
Altman Z-Score
What Is Smart Money Doing with PRCT?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Sharma Pooja | officer | Sale | 4,710 | $93K | Nov 6, 2026 |
| Mack Michael | director | Buy | 7,727 | - | Oct 2, 2026 |
| Waters Kevin | officer | Sale | 373 | $8K | Sep 9, 2026 |
| Nouri Alaleh | officer | Sale | 297 | $6K | Sep 9, 2026 |
| Templin Barry L | officer | Sale | 373 | $8K | Sep 9, 2026 |
| Desai Antal Rohit | director | Buy | 3,315 | - | Jun 9, 2026 |
| Dodrill Amy M. | director | Buy | 3,315 | - | Jun 9, 2026 |
| Garrett Mary | director | Buy | 3,315 | - | Jun 9, 2026 |
| Harris Taylor C. | director | Buy | 3,315 | - | Jun 9, 2026 |
| Little Elisabeth Sandoval | director | Buy | 3,315 | - | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PRCT Growth Story
Revenue YoY
37.2%
3yr Revenue CAGR
60.1%
EPS Growth YoY
1.71%
FCF Growth YoY
43.7%
Revenue Trend
STRONG
Dark Pool Trades for PRCT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PRCT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:36 | $23.51 | 1,037 | $$24K | SELL |
| 21:00:35 | $23.51 | 6,754 | $$159K | SELL |
| 21:00:35 | $23.51 | 1,204 | $$28K | SELL |
| 21:00:35 | $23.51 | 1,022 | $$24K | SELL |
| 21:00:00 | $23.51 | 1,000 | $$24K | SELL |
5 dark pool trades shown · $$259K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PRCT
PREVIEWSEPT Investing provides real-time options flow tracking for PRCT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $25 | Jan 15 | 64 | $$20.5K | 100 | BLOCK |
| PUT | $22.5 | Apr 16 | 155 | $$3000 | 10 | SWEEP |
| CALL | $30 | Dec 18 | 36 | $$90 | 3 | SWEEP |
| CALL | $30 | Dec 18 | 36 | $$150 | 5 | SWEEP |
4 options trades shown · 75% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PROCEPT BioRobotics Corp (PRCT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PRCT — frequently asked questions
What is PRCT stock price today?
PROCEPT BioRobotics Corp (PRCT) is at $23.51, up 0.73% (+$0.17) at the Nov 12, 2026 close.
Why is PRCT stock moving today?
Latest PRCT news — Nov 6, 2026: PROCEPT BioRobotics Corp filed an insider trading report (Form 4) · Nov 6, 2026: Truist Securities keeps PROCEPT BioRobotics at Hold, lifts price target to $24
Why did PRCT stock move on Nov 6, 2026?
PROCEPT BioRobotics shares closed at $20.62, up 2.38% on the day, trading between a low of $19.41 and a high of $20.80 on volume of 1,661,475. The move came as two analysts raised their price targets: Truist Securities lifted its target to $24 while maintaining a Hold rating, and UBS raised its target to $21 while keeping a Neutral rating.
What is the PRCT price target?
The average analyst price target for PRCT is $25.00, ranging from $21 to $35, based on 9 analysts. Latest: UBS maintains on Nov 6, 2026.
What do analysts rate PRCT?
Analyst ratings for PRCT: 0 Buy, 8 Hold, 3 Sell — consensus Hold.
Did PRCT beat earnings?
PRCT last reported on Nov 4, 2026: EPS -$0.46 vs -$0.39 expected — a miss of 17.5%.
Does PRCT pay a dividend?
PRCT does not currently pay a dividend.
How much debt does PRCT have?
PROCEPT BioRobotics Corp reported $52M of debt and $218M of cash (Sep 30, 2026).
What are PRCT support and resistance levels?
Support: $21.56, $19.41, $17.49. Resistance: $24.07, $25.95, $27.80.
What are insiders doing with PRCT?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on PRCT?
Nov 6, 2026: PROCEPT BioRobotics Corp filed an insider trading report (Form 4) · Nov 6, 2026: Truist Securities keeps PROCEPT BioRobotics at Hold, lifts price target to $24 · Nov 6, 2026: Truist Securities keeps Hold rating on PROCEPT BioRobotics, lifts price target to $24